Krensavage Asset Management as of Sept. 30, 2017
Portfolio Holdings for Krensavage Asset Management
Krensavage Asset Management holds 14 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Enanta Pharmaceuticals (ENTA) | 14.8 | $47M | 1.0M | 46.80 | |
| Gilead Sciences (GILD) | 13.2 | $42M | 521k | 81.02 | |
| United Therapeutics Corporation (UTHR) | 12.7 | $41M | 347k | 117.19 | |
| Bioverativ | 11.2 | $36M | 630k | 57.07 | |
| Sucampo Pharmaceuticals | 10.4 | $33M | 2.8M | 11.80 | |
| Merck & Co (MRK) | 7.7 | $25M | 384k | 64.03 | |
| Orthofix International Nv Com Stk | 7.2 | $23M | 487k | 47.25 | |
| Halyard Health | 6.7 | $22M | 479k | 45.03 | |
| RTI Biologics | 6.3 | $20M | 4.4M | 4.55 | |
| Invacare Corporation | 5.5 | $18M | 1.1M | 15.75 | |
| CONMED Corporation (CNMD) | 3.1 | $10M | 192k | 52.47 | |
| Aviragen Therapeutics | 0.6 | $2.0M | 2.8M | 0.69 | |
| Digirad Corporation | 0.4 | $1.2M | 334k | 3.45 | |
| Juniper Pharmaceuticals Incorporated | 0.3 | $1.1M | 243k | 4.55 |
